Skip to main content
. 2022 Oct 31;12(10):e059626. doi: 10.1136/bmjopen-2021-059626

Table 2.

Results of the PCR performed in nasopharyngeal swabs for virus identification in the infants hospitalised in paediatric general wards for acute bronchiolitis between 2017 and 2021

Pre-COVID-19 Post-COVID-19 P value*
2017–2018 2018–2019 2019–2020 2017–2020
aggregated data
2020–2021
Infants, n 479 451 417 1347 205
Nasal PCR†, n (%) 245 (51.1) 274 (60.7) 281 (67.4) 800 (59.4) 167 (74.2) <0.01
 Respiratory syncytial virus 193 (78) 202 (73) 211 (75) 606 (75) 120 (71) 0.3
 Rhinovirus 41 (17) 65 (24) 63 (22) 169 (12) 44 (21) 0.1
 Adenovirus 17 (7) 10 (4) 14 (5) 16 (11) 12 (7) 0.3
 Metapneumovirus 17 (7) 10 (4) 10 (4) 37 (2.7) 19 (11) 0.001
 Influenzae A 0 (0) 2 (0.4) 1 (0.2) 3 (0.2) 0 (0) 0.4
 Influenzae B 0 (0) 2 (0.7) 1 (0.3) 3 (0.2) 0 (0) 0.4
 Parainfluenzae 3 9 (4) 6 (2) 10 (4) 27 (2) 16 (10) <0.01
 Bocavirus 6 (2) 11 (4) 7 (2) 24 (1.7) 14 (8) 0.001
 SARS-CoV-2 0 (0) 0 (0) 0 (0) 0 (0) 3 (2) 0.02
 Coronavirus NL63 2 (0.8) 5 (2) 3 (1) 10 (0.7) 9 (5) <0.01
 Coronavirus OC43 0 (0) 1 (0.3) 2 (0.7) 3 (0.2) 7 (4) <0.01
No PCR, n (%) 234 (48.8) 177 (39) 136 (32) 547 (40) 38 (18) <0.01

*P value for the comparison between pre-COVID-19 aggregated data and COVID-19 data using χ2 test.

†Virus identifications by PCR in nasopharyngeal swabs or aspirates were performed by means of Allplex Respiratory Panel Assays (Seegene) and/or Simplexa Flu A/B & RSV Direct Gen II Kit (Diasorin Molecular).